tiprankstipranks
Orthofix International N.V. (OFIX)
NASDAQ:OFIX
US Market
Holding OFIX?
Track your performance easily

Orthofix (OFIX) Earnings Dates, Call Summary & Reports

71 Followers

Earnings Data

Report Date
Mar 03, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.27
Last Year’s EPS
-0.59
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Oct 29, 2018
|
% Change Since: -1.47%
|
Next Earnings Date:Aug 06, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong performance in the U.S., particularly in spine fixation and orthopedics, with robust financial results and strategic initiatives to drive future growth. While there were challenges in the U.S. biologics segment and international sales, the overall outlook remains positive with new financial targets and successful refinancing.
Company Guidance
During the Orthofix Q3 2024 earnings call, the company provided detailed financial guidance and outlined strategic goals for the coming years. Orthofix reported net sales of $196.6 million, reflecting a 7% year-over-year growth on a constant currency basis. The company achieved a positive free cash flow of $5.9 million, earlier than expected. For 2024, Orthofix reaffirmed its financial guidance, projecting full-year net sales between $795 million and $800 million and non-GAAP adjusted EBITDA of $64 million to $69 million. Looking ahead, Orthofix introduced its 2027 financial targets, aiming for a 6% to 7% net sales CAGR and mid-teens non-GAAP adjusted EBITDA as a percentage of net sales by 2027. The company's growth strategy focuses on innovation, market penetration, and leveraging their comprehensive product portfolio to drive sustained above-market growth across their spine fixation and orthopedics businesses.
Record Performances in U.S. Orthopedics and 7D Unit Placements
Orthofix achieved record performances in U.S. orthopedics sales and matched the highest number of 7D unit placements in any quarter to date.
Strong Financial Performance
The company reported net sales of $196.6 million, a 7% year-over-year growth on a constant currency basis, and achieved positive free cash flow of $5.9 million.
U.S. Spine Fixation Growth
U.S. spine fixation revenue grew 18%, more than triple the market rate, driven by strong demand for new products like Reef and WaveForm interbody products.
Bone Growth Therapies Growth
The Bone Growth Therapies segment grew 9% overall, with 13% growth in the fracture market.
Refinancing to Support Growth
Orthofix successfully completed a new $275 million financing to replace its existing credit facility, optimizing its capital structure for long-term growth.
Introduction of New Financial Targets
Orthofix introduced new 2027 financial targets, projecting mid-teens non-GAAP adjusted EBITDA as a percent of net sales and positive free cash flow from 2025 to 2027.
---

Orthofix (OFIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OFIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 20182018 (Q2)
- / 0.42
0.420.00% (0.00)
Oct 29, 20182018 (Q3)
- / 0.43
0.422.38% (+0.01)
Feb 25, 20192018 (Q4)
- / 0.55
0.525.77% (+0.03)
May 06, 20192019 (Q1)
- / 0.27
0.39-30.77% (-0.12)
Aug 05, 20192019 (Q2)
- / 0.28
0.42-33.33% (-0.14)
Oct 28, 20192019 (Q3)
- / 0.41
0.43-4.65% (-0.02)
Feb 24, 20202019 (Q4)
- / 0.51
0.55-7.27% (-0.04)
May 08, 20202020 (Q1)
- / 0.09
0.27-66.67% (-0.18)
Aug 06, 20202020 (Q2)
- / -0.59
0.28-310.71% (-0.87)
Nov 05, 20202020 (Q3)
- / 0.31
0.41-24.39% (-0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

OFIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$18.40$18.22-0.98%
Aug 06, 2024$14.59$17.44+19.53%
May 07, 2024$13.46$13.89+3.19%
Mar 05, 2024$13.00$14.13+8.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Orthofix International N.V. (OFIX) report earnings?
Orthofix International N.V. (OFIX) is schdueled to report earning on Mar 03, 2025, TBA Not Confirmed.
    What is Orthofix International N.V. (OFIX) earnings time?
    Orthofix International N.V. (OFIX) earnings time is at Mar 03, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OFIX EPS forecast?
          OFIX EPS forecast for the fiscal quarter 2024 (Q4) is -0.27.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis